Format

Send to:

Choose Destination
See comment in PubMed Commons below
Oncology. 2010;79(1-2):3-12. doi: 10.1159/000318529. Epub 2010 Nov 3.

Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.

Author information

  • 1Department of Surgery, Radiology, Pathology and Medicine, Louisiana State University Health Sciences Center in Shreveport, and Feist-Weiller Cancer Center, Shreveport, La 71130, USA. bli@lsuhsc.edu

Abstract

Inflammatory breast cancer (IBC) is a rare and most aggressive form of breast cancer. The onset and progression of disease are rapid; diagnosis must be made expediently to initiate treatment quickly. In this review, the clinical presentation, trimodal therapy, surgical principles and a brief summary of the Louisiana State University at Shreveport experience with IBC are presented. With this aggressive approach, 5-year survival of better than 40-50% can be expected. This represents a substantive improvement in clinical outcome for IBC patients compared with 30 years ago.

Copyright © 2010 S. Karger AG, Basel.

PMID:
21051912
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk